Serina Therapeutics (SER) Non-Current Debt (2018 - 2024)
Historic Non-Current Debt for Serina Therapeutics (SER) over the last 7 years, with Q3 2024 value amounting to $693000.0.
- Serina Therapeutics' Non-Current Debt changed 0.0% to $693000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $693000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $10.5 million for FY2022, which is 7284.72% up from last year.
- As of Q3 2024, Serina Therapeutics' Non-Current Debt stood at $693000.0, which was down 0.0% from $693000.0 recorded in Q2 2024.
- In the past 5 years, Serina Therapeutics' Non-Current Debt ranged from a high of $10.5 million in Q4 2022 and a low of $693000.0 during Q3 2023
- Over the past 5 years, Serina Therapeutics' median Non-Current Debt value was $5.3 million (recorded in 2021), while the average stood at $4.9 million.
- Per our database at Business Quant, Serina Therapeutics' Non-Current Debt soared by 152041.88% in 2020 and then tumbled by 9311.68% in 2024.
- Serina Therapeutics' Non-Current Debt (Quarter) stood at $3.9 million in 2020, then surged by 55.44% to $6.1 million in 2021, then skyrocketed by 72.85% to $10.5 million in 2022, then plummeted by 93.39% to $693000.0 in 2023, then changed by 0.0% to $693000.0 in 2024.
- Its Non-Current Debt was $693000.0 in Q3 2024, compared to $693000.0 in Q2 2024 and $693000.0 in Q1 2024.